NO20052167L - Hjelpemidler eller preventivmidler mot urineringsfrekvens eller urinkontinens og morfinanderivater med nitrogenholdig heterocyklisk gruppe - Google Patents

Hjelpemidler eller preventivmidler mot urineringsfrekvens eller urinkontinens og morfinanderivater med nitrogenholdig heterocyklisk gruppe

Info

Publication number
NO20052167L
NO20052167L NO20052167A NO20052167A NO20052167L NO 20052167 L NO20052167 L NO 20052167L NO 20052167 A NO20052167 A NO 20052167A NO 20052167 A NO20052167 A NO 20052167A NO 20052167 L NO20052167 L NO 20052167L
Authority
NO
Norway
Prior art keywords
urinary incontinence
diseases
nitrogen
contraceptives
urination
Prior art date
Application number
NO20052167A
Other languages
English (en)
Inventor
Koji Kawai
Kuniaki Kawamura
Naoki Izumimoto
Morihiro Fujimura
Toshikazu Komagata
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of NO20052167L publication Critical patent/NO20052167L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Morfinanderivat av formel (I), hvor R1er metyl, syklopropylmetyl eller lignende; R2 og R3 er hydroksy, metoksy, acetoksy eller lignende; både Y og Z er valensbindinger, -C(=O)- eller lignende; X er C2-C5-karbonkjede (ett av karbonatomene kan være substituert med oksygen, svovel eller nitrogen) som utgjør en del av ringstrukturen eller lignende; (R4)k er substituert eller ikke-substituert benzenkondensert ring, karbonylgruppe eller lignende; R9 er hydrogen eller lignende; R10 og R11 er sammenbundet til å representere -O- eller lignende, og R6 er hydrogen eller lignende, eller et farmasøytisk akseptabelt syreaddisjonssalt derav. Det er også tilveiebrakt et terapeutisk eller profylaktisk middel for urineringshyppighet eller urininkontinens, innbefattende som en effektiv bestanddel, morfinanderivatet eller det farmasøytisk akseptable syreaddisjonssaltet derav; en fremgangsmåte for terapi eller profylakse av sykdommene, og anvendelse for sykdommene. Forbindelsene ifølge oppfinnelsen er nyttige som et nytt terapeutisk eller profylaktisk middel for urineringshyppighet eller urininkontinens, er frie for bivirkninger, og nyttige for terapi eller profylakse av sykdommene og for anvendelse for sykdommene.
NO20052167A 2002-10-09 2005-05-03 Hjelpemidler eller preventivmidler mot urineringsfrekvens eller urinkontinens og morfinanderivater med nitrogenholdig heterocyklisk gruppe NO20052167L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002295616 2002-10-09
PCT/JP2003/012890 WO2004033457A1 (ja) 2002-10-09 2003-10-08 頻尿もしくは尿失禁の治療または予防剤および含窒素環状置換基を有するモルヒナン誘導体

Publications (1)

Publication Number Publication Date
NO20052167L true NO20052167L (no) 2005-06-16

Family

ID=32089217

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052167A NO20052167L (no) 2002-10-09 2005-05-03 Hjelpemidler eller preventivmidler mot urineringsfrekvens eller urinkontinens og morfinanderivater med nitrogenholdig heterocyklisk gruppe

Country Status (17)

Country Link
US (1) US7320984B2 (no)
EP (1) EP1555266B1 (no)
JP (1) JP4016986B2 (no)
KR (1) KR101060629B1 (no)
CN (1) CN100537573C (no)
AU (1) AU2003272944B2 (no)
BR (1) BR0314754A (no)
CA (1) CA2501389C (no)
ES (1) ES2479042T3 (no)
HK (1) HK1079786B (no)
IL (1) IL166944A (no)
MA (1) MA27454A1 (no)
MX (1) MXPA05003723A (no)
NO (1) NO20052167L (no)
NZ (1) NZ539199A (no)
WO (1) WO2004033457A1 (no)
ZA (1) ZA200502650B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060177381A1 (en) * 2002-02-15 2006-08-10 Howard Brooks-Korn Opiopathies
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
KR101233289B1 (ko) * 2004-03-30 2013-02-14 도레이 카부시키가이샤 지양제
AR053098A1 (es) 2004-11-04 2007-04-25 Toray Industries Analgesico derivado de morfinano
JPWO2006104280A1 (ja) * 2005-03-31 2008-09-11 武田薬品工業株式会社 糖尿病の予防・治療剤
ES2464593T3 (es) 2005-11-09 2014-06-03 Toray Industries, Inc. Agente terapéutico o profiláctico para trastornos funcionales digestivos
US8106065B2 (en) * 2005-12-21 2012-01-31 Toray Industries, Inc. Antitussive agent
CA2687955C (en) 2007-05-21 2015-06-30 Toray Industries, Inc. Crystalline micropowder particles
CA2687956C (en) 2007-05-21 2015-03-31 Toray Industries, Inc. Method for producing pharmaceutical tablet
RU2472539C2 (ru) 2007-08-06 2013-01-20 Аллерган, Инк. Способы и устройства для доставки препарата десмопрессина
LT2712622T (lt) * 2008-05-21 2016-09-26 Ferring B.V. Burnoje disperguojamas desmopresinas, skirtas nikturijos netrikdomo miego pirminio periodo pailginimui
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
JP5648480B2 (ja) * 2008-10-24 2015-01-07 東レ株式会社 ４，５−エポキシモルヒナン誘導体を含有する安定な錠剤
WO2010083384A2 (en) * 2009-01-16 2010-07-22 Virginia Commonwealth University Non-peptidyl, potent, and selective mu opioid receptor antagonists
US8623888B2 (en) * 2009-07-15 2014-01-07 Mallinckrodt Llc 3-oxy-hydromorphone derivatives
EP2995614B8 (en) 2010-06-11 2018-03-28 Rhodes Technologies Inc. Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
EP3458061B1 (en) * 2016-05-19 2023-01-18 Virginia Commonwealth University Potent and selective mu opioid receptor modulators
AU2019229892A1 (en) 2018-03-08 2020-09-03 University Of Kansas Treatment of demyelinating diseases
CN109970747B (zh) * 2019-05-05 2020-07-24 潍坊科技学院 一种制备10α-羟基纳呋拉啡的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3318885A (en) * 1965-07-21 1967-05-09 American Cyanamid Co Substituted 6-amino-6, 14-endoethen-ocodides and morphides
JP2525552B2 (ja) * 1992-01-23 1996-08-21 東レ株式会社 モルヒナン誘導体および医薬用途
CA2143864C (en) 1993-07-23 2006-01-24 Hiroshi Nagase Morphinan derivatives and pharmaceutical use thereof
AU5090796A (en) * 1995-03-03 1996-09-23 Algos Pharmaceutical Corporation Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
EP1203771A4 (en) * 1999-07-19 2003-07-30 Toray Industries HEALING OR PREVENTIVE AGENTS FOR THE TREATMENT OF FREQUENCY OF URINATION AND CONTINUITY
WO2002080918A1 (fr) * 2001-04-02 2002-10-17 Toray Industries, Inc. Agent therapeutique ou prophylactique en cas de miction frequente ou d'incontinence urinaire

Also Published As

Publication number Publication date
MA27454A1 (fr) 2005-07-01
JPWO2004033457A1 (ja) 2006-04-27
BR0314754A (pt) 2005-07-26
CN1703415A (zh) 2005-11-30
HK1079786A1 (en) 2006-04-13
CA2501389A1 (en) 2004-04-22
US7320984B2 (en) 2008-01-22
ES2479042T3 (es) 2014-07-23
EP1555266B1 (en) 2014-05-21
EP1555266A4 (en) 2006-12-06
KR101060629B1 (ko) 2011-08-31
NZ539199A (en) 2008-09-26
AU2003272944B2 (en) 2009-11-12
US20060040970A1 (en) 2006-02-23
MXPA05003723A (es) 2005-09-30
HK1079786B (zh) 2010-03-12
CA2501389C (en) 2013-01-08
CN100537573C (zh) 2009-09-09
WO2004033457A1 (ja) 2004-04-22
AU2003272944A1 (en) 2004-05-04
EP1555266A1 (en) 2005-07-20
KR20050056232A (ko) 2005-06-14
JP4016986B2 (ja) 2007-12-05
IL166944A (en) 2010-11-30
ZA200502650B (en) 2006-06-28

Similar Documents

Publication Publication Date Title
NO20052167L (no) Hjelpemidler eller preventivmidler mot urineringsfrekvens eller urinkontinens og morfinanderivater med nitrogenholdig heterocyklisk gruppe
NO20044974L (no) Imidazo [1,2-a]pyrazin-8-ylaminer, fremgangsmater for fremstilling og anvendelse derav
IE911977A1 (en) Inhibition of 5-lipoxygenase and cyclooxygenase products
ATE227727T1 (de) Thienotriazolodiazepinverbindungen und ihre medizinischen anwendungen
HUP0300148A2 (en) Dipeptide nitrile cathepsin k inhibitors, process for their preparation and pharmaceutical compositions containing them
IS7709A (is) Pýrasóló[3,4-b]pýridín efnasambönd, og notkun þeirra sem fosfórdíesterasa hindrar
TW200619212A (en) Morpholine derivatives
WO2005011656A3 (en) Pyridyl derivatives and their use as therapeutic agents
JO2353B1 (en) New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
MX2007003321A (es) Derivados heterociclicos y su uso como agentes terapeuticos.
DK1533292T3 (da) Dibenzylaminforbindelse og medicinsk anvendelse deraf
NO20055421L (no) Kinolinderivater som fosfodiestrase-inhibitorer
WO2005011654A3 (en) Pyridyl derivatives and their use as therapeutic agents
JO2282B1 (en) Oxazole derivatives
NO20055655L (no) Anvendelse av azetidinkarboksamidderivater i terapi
ATE402175T1 (de) 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1, - naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren
BG108426A (en) Novel sulfonic acid derivatives
MXPA03008134A (es) Compuesto de n-fenilarilsulfonamida, medicamento que contiene el compuesto como ingrediente activo, intermediario para el compuesto y procedimientos para su produccion.
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
EA200400545A1 (ru) Новые замещенные 4-фенил-4-[1h-имидазол-2-ил] пиперидиновые производные и их применение в качестве селективных непептидных агонистов дельта-опиоидов
NZ533795A (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0203118A2 (hu) Béta-diszubsztituált metalloproteáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ES2111086T3 (es) Compuestos triciclicos anfoteros como agentes antihistaminicos y antialergicos.
NO20013408L (no) Anvendelse av 2-substituerte 1,2-benzisotiazol-derivater og 3- substituerte tetrahydropyridopyrimidinon-derivater for profylakseog terapi av cerebral ischemi
EP2266566A3 (en) Nicotinamide derivatives and their use as therapeutic agents

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application